Boris Jordan



Boris Jordan Recent News

Curaleaf Reports Record Q4 Revenue Of $345M, Narrows Loss On Higher Sales, Growing Market Share
Inside Curaleaf's Growth Strategy: Boris Jordan's Vision For Cannabis Market Dominance Through Flower Quality
Cannabis Stocks Jump As Germany Legalizes Marijuana Possession
The Highs And Lows Of Cannabis Stocks In 2023: A Year In Review
Curaleaf's Boris Jordan Predicts Major Turnaround For Cannabis In 2024
Curaleaf Will Ring Opening Bell At Toronto Stock Exchange To Celebrate Landmark Listing
Curaleaf Is One Step Closer To Trading On Toronto Stock Exchange
Curaleaf Holdings Reports Q3 2023 Cannabis Revenue Of $333M, 23% EBITDA Margin
Curaleaf Wants To Uplist To Toronto Stock Exchange, Applies Its Subordinate Voting Shares
EXCLUSIVE: Curaleaf's Boris Jordan Puts Premium On Cannabis Quality, Says 'We Want To Be The Best'
EXCLUSIVE: Europe Is The Biggest Opportunity For Growth In The Cannabis Sector,' Curaleaf's Boris Jordan Tells Benzinga Cannabis Capital Conference
Curaleaf Ready To Raise CA$16.2M With Securities Offering
EXCLUSIVE: The SAFER Banking Act Is A Long-Awaited First Step Towards The Economic Legitimacy Of The Cannabis Industry, Says Benzinga Cannabis Capital Conference Panelist
Cannabis Banking Reform Sparks Reactions From Advocates, Marijuana Retail Giants
Curaleaf Arizona Workers Rally For Rights On Heels Of Teamster Success In Cannabis Sector
Discover Wellness: The Latest In Cannabis-Infused Beverages & Gummies Redefining Tomorrow
EXCLUSIVE: Curaleaf Chairman Predicts DEA's Future Steps On Cannabis Rescheduling
Top Cannabis Experts Explain US Agency's Move To Relax Marijuana Laws: Is Legalization Here? Or Another Red Herring?
Weed-Infused Beverage By Curaleaf Hits The Shelves, Here's Where You Can Find It
Curaleaf Poised To Dominate German Cannabis Market As Government Moves To Legalize
Cannabis Industry's Rapid Growth Led To Oversupply, Similar To Other Industries; Now, We Adjust - Curaleaf CIO
Curaleaf's Boris Jordan: No Capital Raises Planned, Company Has $50M In Revolving Credit
Curaleaf's Q2 2023 Revenue Up 1% Sequentially To $339M, 4% Increase YoY & Adjusted EBITDA $70M